ADARx Pharmaceuticals Upsized IPO Priced at Top of Views

By Colin KellaherShares of ADARx Pharmaceuticals are due to make their trading debut Friday after the clinical-stage biotechnology company's upsized initial public offering was priced at the high end of expectations, raising about $446.3 million.ADARx late Thursday said it is selling nearly 26.3 mi…